MedPath
HSA Approval

PANTOLEXIN POWDER FOR SOLUTION FOR INJECTION 40MG/VIAL

SIN17167P

PANTOLEXIN POWDER FOR SOLUTION FOR INJECTION 40MG/VIAL

PANTOLEXIN POWDER FOR SOLUTION FOR INJECTION 40MG/VIAL

January 16, 2025

PHARMAKOE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAKOE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

A02BC02

Manufacturer Information

PHARMAKOE PTE. LTD.

LABORATORIOS NORMON S.A.

Active Ingredients

Pantoprazole sodium sesquihydrate 45.1mg eqvt to Pantoprazole

40mg/vial

Pantoprazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PANTOLEXIN POWDER FOR SOLUTION FOR INJECTION 40MG/VIAL - HSA Approval | MedPath